Rooijakkers SHM - Search Results

1

Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3.

Boero E, Cruz AR, Pansegrau W, Giovani C, Rooijakkers SHM, van Kessel KPM, van Strijp JAG, Bagnoli F, Manetti AGO. Boero E, et al. Among authors: rooijakkers shm. Front Immunol. 2022 Mar 11;13:834711. doi: 10.3389/fimmu.2022.834711. eCollection 2022. Front Immunol. 2022. PMID: 35359919 Free PMC article.

2

Anti-opsonic properties of staphylokinase.

Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA. Rooijakkers SH, et al. Microbes Infect. 2005 Mar;7(3):476-84. doi: 10.1016/j.micinf.2004.12.014. Epub 2005 Feb 26. Microbes Infect. 2005. PMID: 15792635 Free article.

3

Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.

Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA. Rooijakkers SH, et al. Nat Immunol. 2005 Sep;6(9):920-7. doi: 10.1038/ni1235. Epub 2005 Aug 7. Nat Immunol. 2005. PMID: 16086019

4

Staphylococcal innate immune evasion.

Rooijakkers SH, van Kessel KP, van Strijp JA. Rooijakkers SH, et al. Trends Microbiol. 2005 Dec;13(12):596-601. doi: 10.1016/j.tim.2005.10.002. Epub 2005 Oct 19. Trends Microbiol. 2005. PMID: 16242332 Review.

5

The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.

van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. van Wamel WJ, et al. J Bacteriol. 2006 Feb;188(4):1310-5. doi: 10.1128/JB.188.4.1310-1315.2006. J Bacteriol. 2006. PMID: 16452413 Free PMC article.

6

Bacterial complement evasion.

Rooijakkers SH, van Strijp JA. Rooijakkers SH, et al. Mol Immunol. 2007 Jan;44(1-3):23-32. doi: 10.1016/j.molimm.2006.06.011. Epub 2006 Jul 27. Mol Immunol. 2007. PMID: 16875737 Review.

7

Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus.

Rooijakkers SH, Ruyken M, van Roon J, van Kessel KP, van Strijp JA, van Wamel WJ. Rooijakkers SH, et al. Cell Microbiol. 2006 Aug;8(8):1282-93. doi: 10.1111/j.1462-5822.2006.00709.x. Cell Microbiol. 2006. PMID: 16882032

8

Staphylococcal complement inhibitor: structure and active sites.

Rooijakkers SH, Milder FJ, Bardoel BW, Ruyken M, van Strijp JA, Gros P. Rooijakkers SH, et al. J Immunol. 2007 Sep 1;179(5):2989-98. doi: 10.4049/jimmunol.179.5.2989. J Immunol. 2007. PMID: 17709514

9

Staphylococcal complement evasion by various convertase-blocking molecules.

Jongerius I, Köhl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH. Jongerius I, et al. J Exp Med. 2007 Oct 1;204(10):2461-71. doi: 10.1084/jem.20070818. Epub 2007 Sep 24. J Exp Med. 2007. PMID: 17893203 Free PMC article.

10

Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.

Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P. Rooijakkers SH, et al. Nat Immunol. 2009 Jul;10(7):721-7. doi: 10.1038/ni.1756. Epub 2009 Jun 7. Nat Immunol. 2009. PMID: 19503103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters